Dyslipidemia

M Arvanitis, CJ Lowenstein - Annals of internal medicine, 2023 - acpjournals.org
Dyslipidemia is an important risk factor for coronary artery disease and stroke. All persons
with dyslipidemia should be advised to focus on lifestyle interventions, including regular …

[HTML][HTML] Pitavastatin to prevent cardiovascular disease in HIV infection

SK Grinspoon, KV Fitch, MV Zanni… - … England Journal of …, 2023 - Mass Medical Soc
Background The risk of cardiovascular disease is increased among persons with human
immunodeficiency virus (HIV) infection, so data regarding primary prevention strategies in …

[HTML][HTML] Novel pharmacological therapies for the management of hyperlipoproteinemia (a)

CE Kosmas, MD Bousvarou… - International Journal of …, 2023 - mdpi.com
Lipoprotein (a)[Lp (a)] is a well-established risk factor for cardiovascular disease,
predisposing to major cardiovascular events, including coronary heart disease, stroke, aortic …

Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale

J Joseph, NM Pajewski, RJ Dolor… - Journal of the …, 2023 - Wiley Online Library
Whether initiation of statins could increase survival free of dementia and disability in adults
aged≥ 75 years is unknown. PREVENTABLE, a double‐blind, placebo‐controlled …

Disparities in guideline-recommended statin use for prevention of atherosclerotic cardiovascular disease by race, ethnicity, and gender: a nationally representative …

DA Frank, AE Johnson, LRM Hausmann… - Annals of internal …, 2023 - acpjournals.org
Background: Although statins are a class I recommendation for prevention of atherosclerotic
cardiovascular disease and its complications, their use is suboptimal. Differential underuse …

Association between age and low-density lipoprotein cholesterol response to statins: A danish nationwide cohort study

G Corn, M Melbye, MA Hlatky, J Wohlfahrt… - Annals of Internal …, 2023 - acpjournals.org
Background: There is large patient-to-patient variability in the low-density lipoprotein
cholesterol (LDL-C) response to statin treatment. The reduction in LDL-C may depend on …

[HTML][HTML] Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer

P Huang, X Fan, H Yu, K Zhang, H Li, Y Wang… - Journal of Translational …, 2023 - Springer
Endometrial cancer (EC) is a common gynecological cancer that endangers women health.
Although substantial progresses of EC management have been achieved in recent years …

Sex, racial, and ethnic disparities in acute coronary syndrome: novel risk factors and recommendations for earlier diagnosis to improve outcomes

H Khraishah, R Daher, M Garelnabi… - … , and vascular biology, 2023 - Am Heart Assoc
In this review, sex, racial, and ethnic differences in acute coronary syndromes on a global
scale are summarized. The relationship between disparities in presentation and …

PEER simplified lipid guideline 2023 update: Prevention and management of cardiovascular disease in primary care

MR Kolber, S Klarenbach, M Cauchon, M Cotterill… - Canadian Family …, 2023 - cfp.ca
Objective To update the 2015 clinical practice guideline and provide a simplified approach
to lipid management in the prevention of cardiovascular disease (CVD) for primary care …

Statin initiation and risk of incident kidney disease in patients with diabetes

S Zhou, L Su, R Xu, Y Li, R Chen, Y Cao, P Gao… - Cmaj, 2023 - Can Med Assoc
Background: The role of statin therapy in the development of kidney disease in patients with
type 2 diabetes mellitus (DM) remains uncertain. We aimed to determine the relationships …